obesity clinical trials

Posted on September 29, 2026 by pervial

Eloralintide and Amylin Receptor Agonism: What the Clinical Research Shows

3D visualization of a synthetic peptide binding to an amylin receptor complex in a cellular membrane.

Eloralintide (LY3841136) is an investigational, long-acting selective amylin receptor agonist in clinical development for obesity management. Phase 2 human

Read more Eloralintide and Amylin Receptor Agonism: What the Clinical Research Shows

Tag: obesity clinical trials

Eloralintide and Amylin Receptor Agonism: What the Clinical Research Shows

perVial.com